Pd(<scp>ii</scp>)-catalyzed cascade annulation of N-substituted anilines with CO, NH4OAc and aldehydes to N1-substituted 2,3-dihydroquinazolin-4(1H)-ones-Reference-Cited by-同舟云学术

Pd(ii)-catalyzed cascade annulation of N-substituted anilines with CO, NH₄OAc and aldehydes to N1-substituted 2,3-dihydroquinazolin-4(1H)-ones

Published:2024 Issue:14 Volume:22 Page:2791-2796
ISSN:1477-0520
Container-title:Organic & Biomolecular Chemistry
language:en
Short-container-title:Org. Biomol. Chem.

Author:

Zhang Xiaopeng¹^ORCID,Pang Qiuyang¹,Liu Dan¹,Guo Zhenhua¹,Zhang Guisheng¹^ORCID

Affiliation:

1. NMPA Key Laboratory for Research and Evaluation of Innovative Drug, Collaborative Innovation Center of Henan Province for Green Manufacturing of Fine Chemicals, Key Laboratory of Green Chemical Media and Reactions, Ministry of Education, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang 453007, People's Republic of China

Abstract

N1-substituted 2,3-dihydroquinazolin-4(1H)-ones have been synthesized via Pd-catalyzed annulation of N-substituted anilines with CO, NH4OAc and aldehydes, and the reaction features simple raw materials, high step economy, and good product diversity.

Funder

National Natural Science Foundation of China

Higher Education Discipline Innovation Project

Natural Science Foundation of Henan Province

Henan Key Laboratory of Organic Functional Molecules and Drug Innovation

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/OB/D4OB00055B

Reference35 articles.

1. Studies on 4(1H)-Quinazolinones. 5. Synthesis and Antiinflammatory Activity of 4(1H)-Quinazolinone Derivatives

2. Synthesis of substituted 2,3-dihydro-1-(β-phenylethyl)-2-aryl and 2,3-diaryl-4(1H)-quinazolinones and their pharmacological activities

3. Synthesis and Antiinflammatory Screening of Some Quinazoline and Quinazolyl-4-oxoquinazoline Derivatives

4. Design, Synthesis, and Biological Evaluation of Novel Evodiamine Derivatives as Potential Antihepatocellular Carcinoma Agents

5. Catalytic Domain Crystal Structure of Protein Kinase C-θ (PKCθ)